Ryvu Therapeutics S.A. Announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was PLN 5.347 million compared to PLN 8.121 million a year ago. Operating loss was PLN 12.357 million compared to PLN 13.318 million a year ago. Net loss was PLN 12.136 million compared to PLN 3.914 million a year ago. For the nine months, total revenue was PLN 29.667 million compared to PLN 25.523 million a year ago. Operating loss was PLN 24.194 million compared to PLN 34.319 million a year ago. Net loss was PLN 20.745 million compared to PLN 25.165 million a year ago.